Correlation Between ABVC Biopharma and Bioatla

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Bioatla, you can compare the effects of market volatilities on ABVC Biopharma and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Bioatla.

Diversification Opportunities for ABVC Biopharma and Bioatla

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between ABVC and Bioatla is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Bioatla go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Bioatla

Given the investment horizon of 90 days ABVC Biopharma is expected to generate 0.6 times more return on investment than Bioatla. However, ABVC Biopharma is 1.66 times less risky than Bioatla. It trades about -0.15 of its potential returns per unit of risk. Bioatla is currently generating about -0.12 per unit of risk. If you would invest  63.00  in ABVC Biopharma on September 4, 2024 and sell it today you would lose (9.00) from holding ABVC Biopharma or give up 14.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ABVC Biopharma  vs.  Bioatla

 Performance 
       Timeline  
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bioatla is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

ABVC Biopharma and Bioatla Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABVC Biopharma and Bioatla

The main advantage of trading using opposite ABVC Biopharma and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.
The idea behind ABVC Biopharma and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments